Edoxaban for 12 vs. 3 months in cancer-associated isolated distal deep vein thrombosis according to different doses: insights from the ONCO DVT study.
Ryuki ChataniYugo YamashitaTakeshi MorimotoNao MuraokaMichihisa UmetsuYuji NishimotoTakuma TakadaYoshito OgiharaTatsuya NishikawaNobutaka IkedaKazunori OtsuiDaisuke SuetaYukari TsubataMasaaki ShojiAyumi ShikamaYutaka HosoiYasuhiro TanabeKengo TsukaharaNaohiko NakanishiKitae KimSatoshi IkedaKazunori MushiakeKazushige KadotaKoh OnoTakeshi KimuraPublished in: European heart journal. Cardiovascular pharmacotherapy (2024)
NCT03895502 (ONCO DVT Trial): https://classic.clinicaltrials.gov/ct2/show/NCT03895502.